BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 8887915)

  • 41. Laser prostatectomy in patients on anticoagulant therapy or with bleeding disorders.
    van Melick HH; van Venrooij GE; Boon TA
    J Urol; 2003 Nov; 170(5):1851-5. PubMed ID: 14532791
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The KTP-(greenlight-) laser--principles and experiences.
    Bachmann A; Ruszat R
    Minim Invasive Ther Allied Technol; 2007; 16(1):5-10. PubMed ID: 17365672
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Photoselective vaporization of the prostate using a laser high performance system in the canine model.
    Lee R; Saini R; Zoltan E; Te AE
    J Urol; 2008 Oct; 180(4):1551-3. PubMed ID: 18710776
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A prospective randomized trial comparing transurethral resection of the prostate and laser therapy in men with chronic urinary retention: The CLasP study.
    Gujral S; Abrams P; Donovan JL; Neal DE; Brookes ST; Chacko KN; Wright MJ; Timoney AG; Peters TJ
    J Urol; 2000 Jul; 164(1):59-64. PubMed ID: 10840425
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Andrological implications of visual laser ablation of prostate (VLAP).
    Hashmat AI
    Acta Chir Hung; 1994; 34(1-2):177-82. PubMed ID: 7541594
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [State of the art in Nd:Yag laser treatment of benign prostatic hyperplasia].
    Monica B; Barbieri A; Ziveri M
    Acta Biomed Ateneo Parmense; 1997; 68(1-2):27-33. PubMed ID: 9478255
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Holmium laser resection of the prostate versus neodymium:yttrium-aluminum-garnet visual laser ablation of the prostate: a randomized prospective comparison of two techniques for laser prostatectomy.
    Gilling PJ; Cass CB; Malcolm A; Cresswell M; Fraundorfer MR; Kabalin JN
    Urology; 1998 Apr; 51(4):573-7. PubMed ID: 9586609
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical studies on advantages and safety of visual laser ablation for patients with benign prostatic hyperplasia.
    Nasu Y; Watanabe T; Kumon H; Ohmori H
    Int J Urol; 1996 Jan; 3(1 Suppl):S53-4. PubMed ID: 24304025
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Laser treatment of benign prostatic hyperplasia].
    Ogreid P; Wahlqvist R
    Nord Med; 1997 Mar; 112(3):89-92. PubMed ID: 9190566
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Dosimetry using the right angle firing neodymium: YAG laser fiber for treating canine prostate].
    Nishimura K
    Nihon Hinyokika Gakkai Zasshi; 1995 Feb; 86(2):290-5. PubMed ID: 7897930
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of tissue effects produced by the Prolase II lateral-firing neodymium:YAG laser fiber in the canine prostate.
    Gill HS; Kabalin JN; Mikus PW
    Lasers Surg Med; 1994; 15(2):185-90. PubMed ID: 7528315
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Technique and short-term outcome of green light laser (KTP, 80W) vaporisation of the prostate.
    Heinrich E; Schiefelbein F; Schoen G
    Eur Urol; 2007 Dec; 52(6):1632-7. PubMed ID: 17689002
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A review of the recent evidence (2006-2008) for 532-nm photoselective laser vaporisation and holmium laser enucleation of the prostate.
    Naspro R; Bachmann A; Gilling P; Kuntz R; Madersbacher S; Montorsi F; Reich O; Stief C; Vavassori I
    Eur Urol; 2009 Jun; 55(6):1345-57. PubMed ID: 19361906
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Laser prostatectomy: which way forward?
    Anson K; Watson G
    Arch Esp Urol; 1994 Nov; 47(9):903-9. PubMed ID: 7530947
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neodymium:YAG visual laser ablation of the prostate.
    Sengör F; Erdoğan K; Tuzluoğlu D; Onur S; Erol A; Sözer T
    Eur Urol; 1996; 29(4):446-9. PubMed ID: 8791052
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of standard transurethral resection, transurethral vapour resection and holmium laser enucleation of the prostate for managing benign prostatic hyperplasia of >40 g.
    Gupta N; Sivaramakrishna ; Kumar R; Dogra PN; Seth A
    BJU Int; 2006 Jan; 97(1):85-9. PubMed ID: 16336334
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Surgical treatment of benign prostatic hypertrophy].
    Dørflinger T; Frimodt-Møller C; Schou J
    Ugeskr Laeger; 2007 May; 169(20):1895-7. PubMed ID: 17553365
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interstitial laser coagulation of the prostate.
    Williams JC
    Tech Urol; 1996; 2(3):130-5. PubMed ID: 9118420
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of thermal tissue effects induced by contact application of fiber guided laser systems.
    Janda P; Sroka R; Mundweil B; Betz CS; Baumgartner R; Leunig A
    Lasers Surg Med; 2003; 33(2):93-101. PubMed ID: 12913880
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Possible mechanisms of action of transurethral needle ablation of the prostate on benign prostatic hyperplasia symptoms: a neurohistochemical study.
    Zlotta AR; Raviv G; Peny MO; Noel JC; Haot J; Schulman CC
    J Urol; 1997 Mar; 157(3):894-9. PubMed ID: 9072594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.